You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

LIOTHYRONINE SODIUM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Liothyronine Sodium, and when can generic versions of Liothyronine Sodium launch?

Liothyronine Sodium is a drug marketed by Xgen Pharms, Carnegie, Dr Reddys Labs Sa, Mylan, Sigmapharm Labs Llc, Sun Pharm, Teva Pharms Usa, Watson Labs, and Zydus. and is included in ten NDAs.

The generic ingredient in LIOTHYRONINE SODIUM is liothyronine sodium. There are four drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Liothyronine Sodium

A generic version of LIOTHYRONINE SODIUM was approved as liothyronine sodium by XGEN PHARMS on August 17th, 2005.

  Try a Trial

Summary for LIOTHYRONINE SODIUM
Drug patent expirations by year for LIOTHYRONINE SODIUM
Recent Clinical Trials for LIOTHYRONINE SODIUM

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of MinnesotaPhase 1/Phase 2
University of Minnesota - Clinical and Translational Science InstitutePhase 1/Phase 2
Aultman Health FoundationPhase 2

See all LIOTHYRONINE SODIUM clinical trials

Pharmacology for LIOTHYRONINE SODIUM
Drug Classl-Triiodothyronine

US Patents and Regulatory Information for LIOTHYRONINE SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xgen Pharms LIOTHYRONINE SODIUM liothyronine sodium INJECTABLE;INJECTION 076923-001 Aug 17, 2005 RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Teva Pharms Usa LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 211510-002 Oct 26, 2018 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Zydus LIOTHYRONINE SODIUM liothyronine sodium TABLET;ORAL 214803-003 Jan 22, 2021 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.